Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection.Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts.From the company’s inception, Oramed has successfully tested its technology via various animal and human studies on its two flagship products, an orally ingestible insulin capsule, ORMD-0801, and an oral GLP-1 analog (exenatide) capsule


Bank Name Oramed Pharmaceuticals Inc.
Stock Exchange NASDAQ
Symbol ORMP
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
CEO Mr. Nadav Kidron Esq.
Website www.oramed.com
Registered Year 2002